The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands-Reference-Cited by-同舟云学术

The cost-utility of rotavirus vaccination with Rotarix™ (RIX4414) in the Netherlands

Published:2008-02 Issue:8 Volume:26 Page:1118-1127
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Goossens Lucas M.A.,Standaert Baudouin,Hartwig Nico,Hövels Anke M.,Al Maiwenn J.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. Enteropathogens associated with childhood diarrhea in Italy. The Italian Study Group on Gastrointestinal Infections;Caprioli;Pediatr Infect Dis J,1996

2. Rotavirus, in virology;Kapikian,2001

3. Rotavirus vaccines: an overview;Midthun;Clin Microbiol Rev,1996

4. Global seasonality of rotavirus infections;Cook;Bull World Health Organ,1990

5. Kemmeren J, Mangen MJJ, van Duynhoven YTHP, Havelaar AH, Rotavirus, in priority setting of foodborne pathogens. Disease burden and costs of selected enteric pathogens. RIVM report 330080001/2006; 2006, Rijksinstituut voor Volksgezondheid en Milieu (National Institute for Public Health and the Environment): Bilthoven.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country;Vaccines;2023-04-28

2. Is vaccination good value for money? A review of cost-utility analyses of vaccination strategies in eight European countries;Epidemiology, Biostatistics, and Public Health;2022-04-01

3. Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs;PharmacoEconomics;2020-11-25

4. Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework;Expert Review of Pharmacoeconomics & Outcomes Research;2019-11-22

5. Economic Evaluation of Human Rotavirus Vaccine in Thailand;Infectious Diseases and Therapy;2019-06-13